Related Experiment Video

Updated: Jun 18, 2026

The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease
15:09

The Use of Primary Human Fibroblasts for Monitoring Mitochondrial Phenotypes in the Field of Parkinson's Disease

Published on: October 3, 2012

Parkinson's disease: Exit toxins, enter genetics

Marie Westerlund1, Barry Hoffer, Lars Olson

  • 1Department of Neuroscience, Karolinska Institutet, Stockholm, Sweden. marie.westerlund@ki.se

Progress in Neurobiology
|November 21, 2009
PubMed

Insights

Genetic variants are now recognized as a primary cause of Parkinson's disease (PD), impacting dopamine neuron survival. This review explores genetic factors and animal models in understanding PD pathogenesis.

Area of Science:

  • Neuroscience
  • Genetics
  • Pathology

Background:

  • Parkinson's disease (PD) was historically viewed as non-hereditary.
  • Environmental factors were extensively studied, but genetic variants are now primary causative factors.
  • Multiple genes and molecular pathways are implicated in dopamine neuron degeneration in PD.

Purpose of the Study:

  • To review the role of genetic variants in Parkinson's disease pathogenesis.
  • To discuss the utility of toxin-based and transgenic animal models in PD research.
  • To summarize current knowledge on common genetic susceptibility factors for PD.

Main Methods:

  • Literature review of genetic studies in Parkinson's disease.
  • Analysis of toxin-based animal models for mechanistic insights.
  • Examination of human genetic data for disease-linked variants.
  • Review of transgenic rodent models developed from genetic findings.

Main Results:

  • Genetic variants are now considered the major causative factor in Parkinson's disease.
  • Numerous genes are implicated, suggesting diverse molecular pathways affecting dopamine neuron survival.
  • Toxin-based and genetically engineered rodent models have advanced understanding of PD mechanisms.

Conclusions:

  • Genetic factors play a crucial role in Parkinson's disease etiology.
  • Understanding genetic susceptibility factors is key to unraveling PD pathogenesis.
  • Animal models, particularly transgenic ones, are vital for studying PD mechanisms and potential therapies.

Related Concept Videos

Parkinson Disease ll: Pathophysiology01:24

Parkinson Disease ll: Pathophysiology

Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
Parkinson Disease l: Introduction01:24

Parkinson Disease l: Introduction

Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
Parkinson's Disease: Overview01:15

Parkinson's Disease: Overview

Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
Parkinson's Disease: Treatment01:24

Parkinson's Disease: Treatment

Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase01:27

Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase

Phase II biotransformation reactions are essential for detoxifying and eliminating xenobiotics, including many pharmaceutical compounds. These reactions typically involve conjugation, the covalent attachment of polar endogenous groups such as glucuronic acid, sulfate, methyl, or acetyl moieties to functional groups introduced during Phase I metabolism. The resulting conjugates are more water-soluble, enabling efficient renal or biliary excretion.The major classes of Phase II enzymes include...
Human Genetics01:28

Human Genetics

Human genetics provides a profound framework for understanding the interplay between genetic predispositions and human psychology. At the heart of this discipline lies the study of how genes influence physical traits, behaviors, and susceptibility to diseases. Each person carries a unique genetic code that subtly or significantly shapes their psychological and behavioral landscape.
The complex relationship between genetics and psychology is observable through common biological components such...